XM does not provide services to residents of the United States of America.

Indian shares set to open flat as US election results trickle in



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian shares set to open flat as US election results trickle in</title></head><body>

Nov 6 (Reuters) -Indian shares are set to open flat on Wednesday, with caution likely to prevail as U.S. presidential election results trickle in.

The Gift Nifty futures GIFc1 were trading at 24,268, as of 07:48 a.m. IST, indicating that the benchmark Nifty 50 .NSEI will open near Tuesday's close of 24,213.3.

Other Asian markets traded lower, with the MSCI Asia ex-Japan index .MIAPJ0000PUS shedding 0.4%, as early results from the U.S. presidential election suggested the race remained too close to call.

Republican Donald Trump won eight states while Democrat Kamala Harris captured three states and Washington, D.C., Edison Research projected, but critical battleground states were unlikely to be called for hours or even days.

A Trump win could lead to lower corporate tax rates in the United States, and is expected to boost spending and benefit several equity sectors in India, according to analysts.

A Harris victory, meanwhile, is seen as a sign of policy continuity, a neutral-to-mildly-positive outcome for Indian stocks, they said.

"Clarity on the outcome of U.S. election will influence markets trajectory in this session," said Deepak Jasani, head of retail research, HDFC Securities.

Indian shares recouped losses to log gains on Tuesday, led by banks, as investors sought safety in segments with cheaper valuations.

The market's recovery in the previous session was driven by short-covering ahead of the U.S. results, but caution persists amid weak earnings and lackluster quarterly results.

Foreign institutional investors sold domestic equities for the 27th consecutive session, offloading stocks worth 25.69 billion Indian rupees, on a net basis.

The benchmark Nifty is about 8% below the all-time high hit on Sept. 27, weighed by record monthly foreign outflows in October as investors directed funds to China from India on Beijing's stimulus measures and cheaper valuations.

The moderation in corporate earnings growth for the September quarter has also weighed on the markets.


STOCKS TO WATCH


** Drugmaker Dr Reddy's Laboratories REDY.NS misses September-quarter profit view on weak U.S. demand

** Mankind Pharma MNKI.NS tops second-quarter profit view on higher demand for chronic drugs

** Titan TITN.NS sees drop in second-quarter profit as gold import tax cut drives inventory losses

** Initial public offering of Swiggy SWIG.NS will open for subscription from Wednesday until Nov. 8, and the stock is expected to list on domestic bourses on Nov. 13





Reporting by Bharath Rajeswaran in Bengaluru; Editing by Sherry Jacob-Phillips

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.